Cognitive
Selank
Approved registered clients only.
Data sheet
Selank
This preview is the one-page Alpine Ascent sheet for Selank. It is the reference copy for reconstitution, frequency, and the figures printed on the sheet. Open it when you want the full page.
What it is
Selank is a research peptide studied for calm focus, stress response, and cognitive support. It is a synthetic tuftsin-based peptide investigated for its potential to reduce anxiety-like responses without strong sedation, while supporting attention, mood stability, and mental clarity. Research interest also includes possible effects on BDNF, neuroplasticity, immune signaling, and stress resilience.
What researchers study it for
- Anxiety and stress-response research
- Calm focus and cognitive support
- Memory and learning support
- Mood stability and resilience
- BDNF and neuroplasticity research
- Immune-modulating support
How it may work
- May influence BDNF and neuroplasticity pathways
- May modulate serotonin and enkephalin pathways
- May support calm focus without strong sedation
- May help regulate stress-related brain signaling
- May provide immune and inflammatory signaling support
Research timeline
1–2 weeks
Calmer mood and reduced stress reactivity may be noticed.
Weeks 3–4
Focus, clarity, and mood stability may begin to improve.
Weeks 4–8
Cognitive support and stress-resilience observations may be recorded.
8+ weeks
Continued calm focus and longer-term support may be assessed.
10 mg research protocol
- Reconstitution
- 1 mL bacteriostatic water
- Final concentration
- 10 mg/mL
- Source dose
- 0.5 mg
- Syringe reference
- 5 units = 0.5 mg
- Frequency
- Once daily
- Research duration
- 4–8 weeks
- Break
- 1–2 weeks off
- Administration
- Intranasal is preferred on the sheet. Subcutaneous is listed as secondary.
Research duration on the sheet: 4–8 weeks, then 1–2 weeks off, on the source sheet.
Reconstitution
- 10 mg + 1 mL bacteriostatic water = 10 mg/mL.
- 5 units = 0.5 mg.
Titration notes
- No dose-escalation schedule is provided.
- The source uses 0.5 mg (5 units) once daily. The sheet says this may be used in anxiety-provoking situations according to the reference.
Important considerations
- For educational and research purposes only.
- Limited human-research data.
- Avoid use in active or recent cancer research subjects.
- Not recommended during pregnancy or breastfeeding.
- Store appropriately after reconstitution.
Evidence summary
- Human research
- Emerging
- Animal research
- Moderate
- Mechanistic evidence
- Moderate
- Long-term safety data
- Limited
References
Completed published studies are listed below and labeled as in vitro, animal, or human research. Favorable and unfavorable results are both included, including cancer studies. This is not every paper on the compound, and it is not a recommendation or a dose.
A completed cancer study of this compound was not identified.
- Selank in generalized anxiety disorder and neurastheniaHuman
62 people. Selank’s calming effect was similar to medazepam, and the report also described an anti-fatigue effect.
- Selank and learning and memory in ratsAnimal
Rats. A single dose during learning was followed by a more stable memory trace over 30 days.
Available strength
10 mg vial. Format: Lyophilized powder.
For educational and research purposes only. These materials are not approved to diagnose, treat, cure, or prevent any disease. Nothing on this page is a dose recommendation or medical advice. The Alpine Ascent data sheet is the reference copy for each compound.